Fred D Finkelman Selected Research

Platelet Activating Factor

3/2015	Effect of premedications in a murine model of asparaginase hypersensitivity.
5/2012	Lyn but not Fyn kinase controls IgG-mediated systemic anaphylaxis.
2/2009	Peanuts can contribute to anaphylactic shock by activating complement.
9/2007	Anaphylaxis: lessons from mouse models.
3/2005	Molecular mechanisms of anaphylaxis: lessons from studies with murine models.
1/2004	Cytokine enhancement of anaphylaxis.
12/2003	Mast cells are required for experimental oral allergen-induced diarrhea.
10/2002	Anti-peptide autoantibodies and fatal anaphylaxis in NOD mice in response to insulin self-peptides B:9-23 and B:13-23.
4/2002	Pathways of anaphylaxis in the mouse.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fred D Finkelman Research Topics

Disease

39	Anaphylaxis (Anaphylactic Shock) 01/2023 - 04/2002
24	Hypersensitivity (Allergy) 01/2022 - 04/2003
22	Inflammation (Inflammations) 01/2018 - 12/2002
20	Asthma (Bronchial Asthma) 01/2020 - 10/2003
15	Infections 01/2024 - 04/2002
15	Food Hypersensitivity (Food Allergy) 01/2022 - 04/2008
8	Mastocytosis 12/2017 - 04/2002
8	Diarrhea 04/2016 - 12/2002
7	Shock 01/2020 - 02/2009
7	Hyperplasia 04/2011 - 02/2004
5	Eosinophilia 01/2020 - 12/2003
5	Atopic Dermatitis (Atopic Eczema) 01/2019 - 07/2006
5	Respiratory Hypersensitivity 12/2017 - 04/2005
4	Hypothermia 01/2022 - 06/2013
4	Autoimmune Diseases (Autoimmune Disease) 01/2016 - 09/2004
3	Nephritis 01/2018 - 07/2002
3	Myasthenia Gravis 01/2016 - 04/2014
3	Experimental Autoimmune Myasthenia Gravis (Autoimmune Experimental Myasthenia Gravis) 01/2016 - 04/2014
3	Immediate Hypersensitivity 03/2015 - 02/2010
3	Schistosomiasis (Bilharziasis) 06/2010 - 04/2008
3	Endotoxemia 06/2010 - 04/2008
3	Nematode Infections 01/2007 - 10/2002
2	Metaplasia 01/2020 - 12/2017
2	Leukemia 10/2019 - 01/2019
2	Pruritus (Itching) 01/2019 - 09/2012
2	Muscle Weakness 04/2015 - 04/2014
2	Peanut Hypersensitivity (Peanut Allergy) 12/2014 - 12/2010
2	Neoplasms (Cancer) 04/2010 - 12/2004
2	Hypereosinophilic Syndrome (Loeffler Endocarditis) 02/2010 - 09/2008
2	Histoplasmosis 02/2005 - 07/2003
1	Egg Hypersensitivity (Egg Allergy) 01/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020

Drug/Important Bio-Agent (IBA)

40	Immunoglobulin E (IgE)IBA 01/2022 - 04/2002
30	Interleukin-4 (Interleukin 4)IBA 01/2021 - 10/2002
29	CytokinesIBA 01/2021 - 10/2002
28	Immunoglobulin G (IgG)IBA 01/2022 - 04/2002
27	AllergensIBA 01/2022 - 10/2003
25	AntigensIBA 01/2021 - 04/2002
25	Interleukin-13IBA 01/2018 - 10/2002
13	Histamine (Histamine Dihydrochloride)FDA Link 01/2023 - 04/2002
12	OvalbuminIBA 05/2012 - 04/2002
10	AntibodiesIBA 01/2020 - 03/2005
9	Platelet Activating FactorIBA 03/2015 - 04/2002
7	anti-IgE antibodiesIBA 01/2019 - 04/2002
6	Peptide Hydrolases (Proteases)FDA Link 01/2018 - 08/2005
6	Proteins (Proteins, Gene)FDA Link 01/2018 - 05/2005
6	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 05/2012 - 03/2005
5	Complement System Proteins (Complement)IBA 01/2016 - 02/2009
5	Interleukin-9 (Interleukin 9)IBA 10/2015 - 10/2002
4	Asparaginase (Elspar)FDA Link 01/2020 - 03/2015
4	IgE Receptors (Fc epsilon RI)IBA 01/2020 - 04/2003
4	Immunoglobulins (Immunoglobulin)IBA 01/2019 - 07/2004
4	Peptides (Polypeptides)IBA 01/2016 - 07/2002
4	Interleukin-10 (Interleukin 10)IBA 01/2016 - 02/2005
3	EnzymesIBA 01/2024 - 09/2007
3	Adrenergic Agents (Adrenergic Drugs)IBA 01/2022 - 09/2007
3	Antigen-Antibody Complex (Immune Complex)IBA 10/2019 - 01/2016
3	Immunoglobulin IsotypesIBA 01/2019 - 04/2002
3	Interleukin-33IBA 01/2018 - 03/2012
3	Phosphotransferases (Kinase)IBA 01/2016 - 05/2012
3	Cholinergic ReceptorsIBA 04/2015 - 01/2007
3	Monoclonal AntibodiesIBA 12/2013 - 12/2004
3	Immunoglobulin A (IgA)IBA 05/2012 - 03/2005
3	ovalbumin-alumIBA 05/2012 - 12/2003
3	Immunoglobulin D (IgD)IBA 08/2009 - 04/2002
3	Serotonin (5 Hydroxytryptamine)IBA 09/2007 - 12/2003
3	STAT6 Transcription FactorIBA 05/2007 - 08/2006
3	InterleukinsIBA 08/2006 - 01/2004
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2023 - 01/2018
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022 - 09/2008
2	VaccinesIBA 01/2021 - 01/2018
2	Interleukin-2 (IL2)IBA 01/2020 - 12/2004
2	Triglycerides (Triacylglycerol)IBA 01/2018 - 02/2013
2	AutoantibodiesIBA 01/2018 - 10/2002
2	muskIBA 01/2016 - 04/2014
2	Tyrosine (L-Tyrosine)FDA Link 05/2012 - 09/2007
2	ArginaseIBA 05/2012 - 06/2010
2	Messenger RNA (mRNA)IBA 03/2012 - 12/2002
2	Trefoil Factor-2IBA 03/2012 - 10/2003
2	Chemokine CCL11IBA 07/2010 - 10/2006
2	CollagenIBA 07/2010 - 04/2008
2	Interleukin-12 (IL 12)IBA 06/2010 - 07/2004
2	EpitopesIBA 07/2007 - 03/2006
2	Amino Acids FDA Link 09/2004 - 10/2002
2	Interferon-gamma (Interferon, gamma)IBA 07/2004 - 12/2002
1	histone deacetylase 3IBA 01/2024
1	Syk KinaseIBA 01/2022
1	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 01/2022
1	Histamine Receptors (Histamine Receptor)IBA 01/2022
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2021
1	AlarminsIBA 01/2021
1	Immunoglobulin Variable RegionIBA 01/2021
1	Omalizumab (Xolair)FDA Link 01/2020
1	ligelizumabIBA 01/2020
1	Histamine H1 Receptors (Histamine H1 Receptor)IBA 01/2019
1	platelet activating factor receptorIBA 01/2019
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 10/2018

Therapy/Procedure

6	Therapeutics 01/2022 - 02/2010
3	Immunotherapy 01/2021 - 09/2004
1	Intravenous Injections 01/2020